Borealis Biosciences emerges from stealth with $202 million CAD from Novartis and Versant
Kidney disease treatment company looks to build on work of Chinook Therapeutics, acquired by Novartis last year.
Kidney disease treatment company looks to build on work of Chinook Therapeutics, acquired by Novartis last year.
Portfolio includes Active Impact, BKR, Cycle H2O, InvestEco, Raven, Renewal, Sandpiper, Spring, The51.
Teladoc Health’s Dr. Karolina Filipowska on increasing access to care in Canada.
Startup’s devices use fluorescent light to spot elevated bacteria levels in wounds.
Founder and CEO Hamed Shahbazi said spin out will unlock “significant shareholder value.”
The total transaction value is dependent on annual performance over 36 months.
Kitchener-Waterloo startup develops AI-enabled communication with the help of OVHcloud.
Hamilton-based Afynia aims to improve the way endometriosis is diagnosed.
American pharmaceutical giant Eli Lilly and medical device provider Topcon Healthcare join as strategic investors.
Biovectra is being purchased for the second time in five years.
The San Diego-based startup is looking to secure FDA and Health Canada clearance for its blood-testing platform.
Startup aims to speed up the technology procurement process for healthcare providers.
Changes in top leadership also hit Faire, Kovo HealthTech, goeasy, CFI, and more.
Partners in the $44-million project include ORX, Well Health, Healwell AI, Tali AI, and Simon Fraser University.
The clinical facility aims to be the first dedicated to producing bioprinted tissue therapeutics in Canada.